Q2 2026 Aveanna Healthcare Holdings Inc Earnings Call Transcript
Key Points
- Revenue increased 13.7% year-over-year to $670.5 million, with growth across all three business segments.
- Adjusted EBITDA rose 8% to $95.4 million, driven by improved rates, higher volumes, and operational efficiencies.
- Secured a significant California private duty nursing rate increase effective January 1, 2027, after years of advocacy, which is expected to boost growth and caregiver recruitment.
- Achieved 37 preferred payer agreements in Private Duty Services, exceeding the goal of 38, and 50 in Home Health, ahead of schedule.
- Raised full-year 2026 guidance to revenue greater than $2.68 billion and adjusted EBITDA greater than $365 million, reflecting strong operational performance.
- Successfully repriced term loan, reducing interest expense by $10 million annually, and received credit rating upgrades from all three major agencies.
- Generated strong free cash flow of $75.4 million year-to-date, with liquidity of $433 million at quarter-end.
- Updated long-term organic growth rates to 5%-6% for Private Duty Services and 8%-10% for Home Health and Hospice, driven by improved government and payer relations.
- Home Health episodic mix reached 81%, with total episodic volume growth of 18.5%, indicating strong payer alignment and margin expansion.
- Family First acquisition integration is progressing well, with expectations to complete most integration by late Q4 2026.
- Labor market remains a primary challenge, with caregiver hiring and retention still difficult despite improvements.
- Private Duty Services gross margin was 28.9%, impacted by ongoing caregiver wage adjustments and non-recurring favorable items in Q2 2025.
- California rate increase will not take effect until January 1, 2027, and proactive wage pass-throughs in late 2026 may pressure margins before benefits are realized.
- Medical Solutions growth is expected to remain in high single digits for the next few quarters, with double-digit growth not expected until early 2027.
- The company faces ongoing uncertainty regarding federal Home Health rate adjustments, including the temporary adjustment issue.
- M&A activity, while robust, is subject to disciplined valuation and leverage targets, potentially limiting near-term inorganic growth.
- Gross margin percentage is expected to remain consistent, with wage pass-throughs limiting margin expansion despite revenue growth.
- California business has been lethargic with fill rates dropping nearly 30%, and recovery will take time to unlock hospital discharges and family-provided care.
- Integration of Family First involves complex back-office and EMR transitions, which could pose execution risks in the second half of 2026.
- The company's long-term EBITDA margin target of 14% may only slightly improve to 15%, limiting significant profitability gains.
Good morning, and welcome to Aveanna Healthcare Holdingsâ second-quarter 2026 earnings conference call. Todayâs call is being recorded, and we have allocated one hour for prepared remarks and Q&A. At this time, Iâd like to turn the call over to Debbie Stewart, Aveannaâs Chief Accounting Officer. Thank you. You may begin.
Good morning, and welcome to Aveannaâs second quarter 2026 earnings call. I am Debbie Stewart, the companyâs Chief Accounting Officer. With me today is Jeff Shaner, our Chief Executive Officer, and Matt Buckhalter, our Chief Financial Officer.
During this call, we will make forward-looking statements. Risk factors that may impact those statements and could cause actual future results to differ materially from currently projected results are described in this morningâs press release and the reports we file with the SEC. The company does not undertake any duty to update such forward-looking statements.
Additionally, during todayâs call, we will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
